Prostatecancer-ipsen.sk.ppt

Comments: recently, a large number of studies have shown that the addition of proton 1H-spectroscopic imaging (1H-MRSI) and dynamic contrast enhanced imaging (DCEMR) to magnetic resonance (MR) could represent a powerful tool for the management of PCa in most of its aspects. This combination of MR techniques can substantially sustain the clinical management of patients with PCa at different levels: in particular, in the initial assessment, reducing the need for more extensive biopsies and directing targeted biopsies; in the definition of a biochemical progression after primary therapies, distinguishing between fibrotic reaction and local recurrence from PCa. In this poster session, was presented an interesting paper about the role of multiparametric MRI (dynamic contrast enhancement and diffusion weighting) in the diagnosis of PCa. Mp-MRI showed a high accuracy in detection of PCa. These results are interesting and underline the need to develop technologies able to overcome the current limitations in PCa imaging, adding to the morphological study the metabolic and functional analysis, so to improve the diagnostic capabilities. Including the spectroscopic analysis (H1-MRI) in the Mp-MRI , could improve thePCa detection rate. LPR and prostate biopsiesPoster sessions 29 and 35 Prostate cancer: prognostic Poster Sessions 62 and 80 Lifestyle factors in active surveillance- smoking status impacts on PSA measures (Burton et al, abstract 743) Worst cancers send early PSA signals: 98 % had increasing or constant PSAV and when PSAV 0.2 (Bektic et al, abstract 747) T2: ERG gene assay correlates with pathological stade and RRP Gleason score (Haese et al, abstract 748) Pre operative sex steroids, estrogen, testosterone and SHBG: significant predictors of BCR after RRP (Salonia et al, abstract 751) Radical Prostatectomy Poster Session 74 Trifecta rates after RP (1) Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic ext